Health & Biotech
Could immunotherapy replace chemo? Here’s one stock that could rise 5x according to broker
ASX Health Stocks: Neuren surges 20pc on ‘historic’ FDA approval, HITIQ snaps up Monash Uni as customer
ASX Health Stocks: Volpara jumps 10pc as US FDA makes new ruling on ‘dense breasts’ language
Weed Week: BOD advances Aqua Phase acquisition with stability testing
Prescient’s PTX-100 granted FDA’s Orphan Drug Designation for all T-cell lymphomas
EZZ signs agreement with University of Auckland to conduct product research
Louie the beagle is beating the odds thanks to PharmAust’s canine cancer trial
Q&A: Nanoveu’s new chairman Dr David Pevcic says the market opportunity for antifouling solar panel coatings is in the billions
ASX Health Stocks: Mesoblast share price jumps as FDA accepts resubmission for Remestemcel-L
Broker says EZZ share price could more than double as the company makes inroads into global markets
As it awaits crucial FDA approval Botanix reckons Aussies have a penchant for backing high-risk companies
PharmAust eyes Phase-3 trial after positive results from canine cancer drug
ASX Health Stocks: Emyria partners with Pax Centre to provide psychedelics therapy for PTSD sufferers
Dr Boreham’s Crucible: Tag it and bag it – Bluechiip’s ready to come in from the cold
Argenica confirms safety of ARG-007 in Phase-1 trial, makes preparations for Phase-2
ASX Health Stocks: Rhythm crashes 45pc after withdrawing TGA application for ColoSTAT
Check Up: Almost half a billion US dollars raised to bring back mammoth, dodo, and Tassie tiger
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.
